22 completed, 2 terminated, 1 unknown, 1 withdrawn. 9 Phase 3, 9 Phase 4, 4 Phase 2, 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
| Phase 4 | 9 | Completed 7, Terminated 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 4 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Vilazodone Hydrochloride: new trials by email Literature Review of Vilazodone Hydrochloride trials Research Report on Vilazodone Hydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies Lithium Carbonate, Lamotrigine, Valproic Acid - Bipolar Disorder | Terminated | University of New Mexico | 1037352 | 2016-09-01 | 2024-03-12 | |
| A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder Vilazodone - Major Depressive Disorder | Phase 3 | Completed | Forest Laboratories | 330 | 2015-05-02 | 2019-09-11 |
| Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) Vilazodone, Placebo, Fluoxetine - Major Depressive Disorder | Phase 3 | Completed | Forest Laboratories | 473 | 2015-02-28 | 2019-10-01 |
| Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo Vilazodone 20 mg, Vilazodone 40 mg, Paroxetine 20 mg - Healthy | Phase 1 | Completed | Forest Laboratories | 202 | 2014-03-01 | 2015-02-12 |
| Vilazodone for Separation Anxiety Disorder Vilazodone, Placebo - Separation Anxiety Disorder | Phase 4 | Completed | New York State Psychiatric Institute | 24 | 2013-12-01 | 2018-03-07 |
| Effects of Treatment on Decision-making in Major Depression Any FDA Approved Antidepressant - Major Depressive Disorder, Healthy Controls | Phase 4 | Completed | Emory University | 53 | 2013-08-01 | 2017-11-21 |
| Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder Placebo, Vilazodone - Major Depressive Disorder | Phase 3 | Completed | Forest Laboratories | 529 | 2013-07-11 | 2019-12-24 |
| Double-Blind Treatment of Major Depressive Disorder With Vilazodone Vilazodone, Citalopram - Major Depressive Disorder | Phase 2 | Completed | University of Chicago | 79 | 2013-05-01 | 2023-02-23 |
| Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder Placebo, Vilazodone - Generalized Anxiety Disorder | Phase 3 | Completed | Forest Laboratories | 415 | 2013-04-30 | 2019-12-18 |
| The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives Vilazodone, Citalopram - Major Depressive Disorder, Anxiety | Phase 4 | Withdrawn | Massachusetts General Hospital | 2013-04-01 | 2016-11-08 | |
| Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction? Vilazodone, Sertraline - Sexual Dysfunction, Major Depressive Disorder | Phase 4 | Terminated | Thomas Jefferson University | 4 | 2013-01-01 | 2016-08-25 |
| Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone Vilazodone - Major Depressive Disorder (MDD) | Phase 3 | Completed | Duke University | 70 | 2012-12-01 | 2015-04-16 |
| Vilazodone for Corticosteroid-Induced Memory Impairment Vilazodone, Placebo, Hydrocortisone - Memory Impairment | Phase 2 | Completed | University of Texas Southwestern Medical Center | 24 | 2012-12-01 | 2019-04-11 |
| Vilazodone for Menopausal Hot Flashes vilazodone, placebo capsules - Hot Flushes | Not applicable | Completed | University of Pennsylvania | 36 | 2012-11-01 | 2015-01-14 |
| Vilazodone for the Treatment of Posttraumatic Stress Disorder Treatment (Viibryd) - PTSD, Depression | Phase 4 | Completed | Southern California Institute for Research and Education | 59 | 2012-10-01 | 2017-04-25 |
| Study of Vilazodone to Treat Social Anxiety Disorder Vilazodone, Placebo - Social Anxiety Disorder | Not applicable | Unknown | The Medical Research Network | 30 | 2012-10-01 | 2014-01-20 |
| Vilazodone Treatment for Marijuana Dependence Vilazodone, Placebo - Marijuana Dependence | Phase 2 | Completed | Medical University of South Carolina | 76 | 2012-08-01 | 2016-08-10 |
| Vilazodone for Treatment of Geriatric Depression Vilazodone; Viibryd, Paroxetine; Paxil - Major Depressive Disorder | Phase 4 | Completed | University of California, Los Angeles | 65 | 2012-07-01 | 2018-05-11 |
| Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder Placebo, Vilazodone - Generalized Anxiety Disorder | Phase 3 | Completed | Forest Laboratories | 680 | 2012-06-30 | 2019-12-18 |
| Safety and Efficacy of Vilazodone in Major Depressive Disorder Placebo, Vilazodone - Major Depressive Disorder | Phase 4 | Completed | Forest Laboratories | 1219 | 2012-04-01 | 2015-05-18 |
Showing 20 of 26. Sign in to see all of them.
Depressive Disorder, Major (16) · Depression (6) · Anxiety Disorders (2) · Depressive Disorder (2) · Generalized Anxiety Disorder (2) · Anxiety, Separation (1) · Bipolar Disorder (1) · Consciousness Disorders (1) · Hot Flashes (1) · Marijuana Abuse (1) · Memory Disorders (1) · Phobia, Social (1) · Sexual Dysfunction, Physiological (1) · Stress Disorders, Post-Traumatic (1)
Forest Laboratories (11) · Duke University (1) · Emory University (1) · Genaissance Pharmaceuticals (1) · Massachusetts General Hospital (1) · Medical University of South Carolina (1) · New York State Psychiatric Institute (1) · Pharmacology Research Institute (1) · Southern California Institute for Research and Education (1) · The Medical Research Network (1) · Thomas Jefferson University (1) · University of California, Los Angeles (1) · University of Chicago (1) · University of New Mexico (1) · University of Pennsylvania (1)
United States (25) · Canada (2) · Bulgaria (1) · Finland (1) · Germany (1) · Romania (1) · Russia (1) · Serbia (1) · Ukraine (1)
Carl Gommoll, MS (2) · Carol R Reed, MD (2) · Emily McCusker, PhD (2) · Giovanna Forero, MA (2) · Aimee L McRae-Clark, PharmD, BCPP (1) · Anita Clayton, MD (1) · Ashwin A Patkar, MD (1) · Boadie W Dunlop, MD (1) · Carol Reed, M.D. (1) · Carrie Reichley (1) · Chandran Prakash (1) · Christophe G Lambert, PhD (1) · E. Sherwood Brown, M.D., Ph.D. (1) · Ellen W Freeman, PhD (1) · Franklin Schneier, MD (1)
PMID 29608461, PMID 22106941, PMID 23216998, PMID 24127687, PMID 24940525, PMID 26693034, PMID 27486544, PMID 19284933, PMID 21527122, PMID 21869687, PMID 25396353, PMID 25470094, PMID 25500685, PMID 25891440, PMID 26039688, PMID 27057414, PMID 27232052, PMID 28177953, PMID 28858440, PMID 28901625, PMID 29071764, PMID 29633166, PMID 29920885, PMID 30986735, PMID 31237566, PMID 31651956, PMID 31744781, PMID 33688834
R21DA034089 (1)